Blossom Genetics Corporation Ltd
 | |
| ISIN | 🆔 |
|---|---|
| Industry | Genetics |
| Founded 📆 | 2019 |
| Founder 👔 | Oskar Fletcher, Oliver Davies, Naeem Dungarwalla |
| Headquarters 🏙️ | , , |
Area served 🗺️ | |
| Members | |
Number of employees | |
| 🌐 Website | www |
| 📇 Address | |
| 📞 telephone | |
Blossom Genetics Corporation Ltd is a United Kingdom-based cannabis genetics company, headquartered in London. Blossom Genetics has one licensed production facility, sales licences, and operations in two countries.[1]
History
Blossom was founded in 2019 by Oskar Fletcher, Oliver Davies, and Naeem Dungarwalla. Blossom Genetics is a patient-focused global organisation that produces and distributes proprietary medicinal cannabis genetics and products.
Global Operations and Exports
Blossom owns and operates global subsidiaries to serve the medical cannabis market in jurisdictions where it is legal and regulated:
Blossom Genetics Portugal – located in Lisbon, Portugal
Blossom Genetics China – located in Shanghai, China
Strategic Partnerships & Acquisitions
In 2019, Blossom announced it had entered into a global partnership with The James Hutton Institute, a scientific research institute in Scotland, to focus on developing cannabis genetics for the global medical market.
Genetic Research
Blossom's genetic research allows them to produce bespoke strains with specific agronomic and pharmaceutical traits demanded by the market. Through modern genetic techniques, they developed the tools necessary for the cost-effective production of cannabis genotypes that meet the needs of growers through improved agronomic performance, focusing on traits such as disease resistance, time from seed to harvest, yield, and vigour.
References
This article "Blossom Genetics" is from Wikipedia. The list of its authors can be seen in its historical and/or the page Edithistory:Blossom Genetics. Articles copied from Draft Namespace on Wikipedia could be seen on the Draft Namespace of Wikipedia and not main one.
